Cash Proceeds Along with Fair Value Disclosures Related to grants Exercises and Vesting Options (Detail) (USD $)
In Thousands, except Per Share data, unless otherwise specified |
3 Months Ended | 6 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2013
|
Jun. 30, 2012
|
Jun. 30, 2013
|
Jun. 30, 2012
|
|||||||||
Schedule Of Cash Proceeds And Weighted Average Fair Values Of Stock Options [Line Items] | ||||||||||||
Proceeds from stock options exercised | $ 621 | $ 145 | $ 697 | $ 422 | ||||||||
Tax benefit related to stock options exercised | [1] | [1] | [1] | [1] | ||||||||
Intrinsic value of stock options exercised | 830 | [2] | 80 | [2] | 853 | [2] | 91 | [2] | ||||
Weighted-average fair value of options granted during period | $ 4.27 | $ 1.78 | $ 4.00 | $ 1.82 | ||||||||
Total fair value of shares vested during the period | $ 404 | $ 473 | $ 718 | $ 1,029 | ||||||||
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Share-based payment award equity instruments options vested in period fair value. No definition available.
|
X | ||||||||||
- Definition
Disclosure of the aggregate tax benefit realized from the exercise of stock options and the conversion of similar instruments during the annual period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The total accumulated difference between fair values of underlying shares on dates of exercise and exercise price on options which were exercised (or share units converted) into shares during the reporting period under the plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|